ArticleChemistry & biodiversity2026
Discussion on the Effects of Extraction Technology on the Anti-Radiation Hematopoietic Injury Efficacy of Qizhen Shengbai Compound: Insights From Index Component Content and Pharmacodynamic Perspective.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Qizhen Shengbai compound (QZSBC) is utilized for the adjunctive treatment and prevention of radiation-induced damage to the hematopoietic system. This study aims to optimize the extraction process of QZSBC. Through network pharmacology prediction and high-performance liquid chromatography (HPLC) verification, along with reference to the 2020 edition of the "Chinese Pharmacopoeia," the key components of QZSBC were identified as salidroside, echinacoside, specnuezhenide, and betaine. The pharmaceutical research was conducted on samples from three extraction processes to detect the content of index components. A comprehensive comparison revealed that the total content of index components was highest in the water-extracted samples. The pharmacodynamic test results showed that the water extraction group had the best effect on the recovery and improvement of hematopoietic system injury of radiation mice. Through orthogonal experiments, it was established that the optimal extraction process involves adding 12 times the volume of water and conducting three rounds of reflux extraction, each lasting 1 h. This study is the first to determine the extraction process of QZSBC through the combination of multiple methods and optimize the extraction process through orthogonal experiments, providing research ideas for the subsequent development of QZSBC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.